WebFeb 9, 2024 · The new firms — Nereid Therapeutics, Transition Bio and Faze Medicines — together with Dewpoint and others have now collectively raised >$300 million in venture capital funding for an idea ... WebCompany profile page for Dewpoint Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information
Dewpoint Therapeutics Completes $150M Series C Financing
WebMar 22, 2024 · A deal worth $745 million for two small-molecule programs, with a lucrative option to expand into other modalities, brings together the diabetes and metabolic disease expertise of Novo Nordisk A/S with an artificial intelligence technology platform from Dewpoint Therapeutics Inc. Boston-based Dewpoint signed on with Bagsvaerd, … WebFinden Sie jetzt 25 zu besetzende Computational Jobs in Vockenhausen auf Indeed.com, der weltweiten Nr. 1 der Online-Jobbörsen. (Basierend auf Total Visits weltweit, Quelle: comScore) ctxtrinityhealth
Dewpoint Therapeutics LinkedIn
WebMay 25, 2024 · BOSTON, May 25, 2024 — Dewpoint Therapeutics Inc., today announced the US Patent and Trademark Office (USPTO) issued the patent “Methods of Screening for Condensate-Associated Specificity and Uses Thereof” (U.S. Patent No. 11,340,231) covering novel technology for screening compounds capable of modulating biomolecular … WebMar 22, 2024 · First biomolecular condensates research collaboration to identify drug candidates related to insulin resistance and diabetic complications ; Dewpoint is eligible to receive up to $55 million near term and up to $690 million of clinical, commercial and sales milestones plus royalties across two commercial products; BOSTON, March 22, 2024 … WebNovocure shakes up C-suite after successful trial of tumor-treating electric fields in lung cancer. Jan 20, 2024 10:46am. ctx technologies inc